One year after launching the CMS Health Tech Ecosystem, officials convened in D.C. to celebrate the Trump administration ...
The big takeaway from the recent Alzheimer’s Association International Conference in London is an economic message: Dementia ...
The world risks a resurgence of the HIV epidemic after international financing to combat the disease suffered a “profound ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics, another ...
Emergency departments across America report dramatic increases in serious injuries from e-bikes and e-scooters,” write CHOP’s ...
Oak Hill Bio, a new company backed by RA Capital and other investors, will take on Ultragenyx and Ionis in developing an ...
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Rarely has a new technology so squarely ...
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Sarepta Therapeutics, the bruised ...
Even as some medical schools heed health secretary Robert F. Kennedy Jr.’s call for more nutrition education, several told ...
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results